PD

Philip Daffas

Mr Daffas has an international career spanning more than 25 years with blue-chip healthcare corporates and novel technology start-up companies. Philip has held senior global business leader positions in Europe, US and Australia. He has been involved in building businesses, growing market share and developing customer and industry relationships in each sector on a global basis. Philip's earlier experience was in Europe with IVAC infusion systems and Shiley cardiopulmonary He subsequently joined Boehringer Mannheim, initially in the UK managing their diagnostics business and subsequently was promoted to a Global Marketing role in the Diabetes Care business cased in Mannheim, Germany. In 1997 Philip joined Cochlear in the UK as the European Sales and Marketing Manager and subsequently was promoted in 2000 to the VP Global Marketing role based in Sydney, Australia Other roles in Australia have included General Manager with Roche Diagnostics, Managing Director at Bio Rad Laboratories and CEO of Applied Physiology, an Australian software start-up company in the intensive care monitoring sector.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
22/12/253,114,226N/A0N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
06/07/26
Transfer
147,059$0.100$14,705Off-market transfer
06/07/26
Transfer
147,059$0.100$14,705Off-market transfer
19/06/26
Issued
605,328$0.105$63,559Issue of securities
22/12/25
Issued
147,059$0.340$50,000Placement
19/12/25
Expiry
200,000$0.280$56,000Options expired